ArticleAsian Pacific journal of cancer prevention : APJCP2024
Immunomodulatory Interventions Based on a Bioinformatics Study of TLR2 in Glioblastoma Multiforme.
Article in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Microbial and metabolic signatures of humanized microbiome mice associate withFrontiers in immunology · 2026Article
- NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biology.European journal of medical research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveOne of the most malignant types of tumors with a remarkable ability of recurrence rate and aggressiveness is glioblastoma multiforme(GBM). Anyway, according to the restricted remedies accessible for the treatment of this serious tumor, there is no confident and stable therapeutic strategy. Notably, bioinformatics analysis can detect many effective genes in the diagnosis and treatment of GBM. MATERIALS AND
methodsUsing large-scale data analysis and bioinformatics, we examined TLR2's role in GBM. We analyzed gene expression datasets from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) to recognize disparately expressed diverse genes (DEGs) associated with TLR2. A protein-protein interaction (PPI) network was constructed to reveal potential molecular partners and functional enrichment analysis elucidated biological activities. In this account, the correlation and association between TLR2 expression and the infiltration of immune cells within the tumor microenvironment were investigated. Results: Our analysis demonstrated significant differential gene expression patterns in GBM, especially TLR2. The PPI network highlighted interactions with key proteins in pathways related to proliferation, invasion, immune evasion, and angiogenesis. Functional enrichment analysis indicated TLR2's involvement in critical signaling processes, including toll-like receptor signaling. Interestingly, TLR2 expression was strongly associated with the infiltration of immune cells, proposing its performance and function in the tumor microenvironment.
conclusionUnderstanding TLR2's functions in glioblastoma and other cancers is vital for developing targeted therapies and immunomodulatory interventions, potentially improving clinical outcomes for patients facing these formidable diseases. Further validation and functional studies are needed to confirm TLR2's role in cancer and expand the prospects for combination therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.